Alcon, a global leader in eye care committed to helping people see brilliantly, has been named one of the ‘Best Employers in Singapore’ for the second consecutive year, following its…
Elucid has announced that Noridian will begin covering AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, starting December 8, 2024. With this decision, five out of…
WellSky, a prominent technology company in health and community care, has announced its acquisition of Bonafide, a software solution designed for durable medical equipment (DME) and home medical equipment (HME)…
Axena Health, Inc., a medical device company focused on female pelvic health, has announced the development of a machine learning model that could help clinicians create personalized treatments for female…
PharmaJet®, a company focused on enhancing injectable performance with its needle-free technology, has announced the results of an implementation study in Nigeria. This study evaluated the impact of administering the…
8×8, Inc. (NASDAQ: EGHT), a prominent provider of business communications, customer experience (CX), and CPaaS platforms, has announced that CareMonitor has successfully implemented 8×8 CPaaS to enhance critical patient interactions.…
A recent study published in the Annals of Hepatology investigated the feasibility of using the AMRA® MAsS Scan, powered by the FDA-cleared AMRA® Profiler 4 device, to assess muscle composition…
AptarGroup, Inc. (NYSE: ATR), a global leader in dosing, dispensing, and protection technologies for drug and consumer products, has announced the award of a contract from the U.S. Federal Government…
Hello Heart, a leader in preventive heart health, has announced its expansion into government markets across the United States. This initiative aims to make its proven heart health tools accessible…
Vivasure Medical®, a leader in fully absorbable technology for percutaneous vessel closure, will reveal the findings from its U.S. PATCH Study at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference in…
Endospan, a leader in endovascular solutions for the Aortic Arch, has announced the completion of enrollment for the primary arm of its TRIOMPHE Investigational Device Exemption (IDE) clinical study, which…
Blue Lake Biotechnology, Inc., a clinical-stage company focused on intranasal vaccines using parainfluenza virus 5 (PIV5) vectors, and its affiliate CyanVac LLC, announced the presentation of positive interim pediatric clinical…